Hussman Strategic Advisors, Inc. Sarepta Therapeutics, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 84,000 shares of SRPT stock, worth $1.58 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
84,000
Previous 63,000
33.33%
Holding current value
$1.58 Million
Previous $1.08 Million
50.23%
% of portfolio
0.38%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding SRPT
# of Institutions
421Shares Held
85.8MCall Options Held
5.66MPut Options Held
6.11M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct68.8MShares$1.29 Billion0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA5.3MShares$99.8 Million0.0% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...